Yale University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Yale University sits in the top decile of US sponsors by registered trial count (#13 of 15,742 sponsors by registered trial count).
Yale University: 1,492 sponsored US clinical trials, 254 recruiting.
Yale University sponsors 1,492 registered US clinical trials on ClinicalTrials.gov, 254 of them currently recruiting, and 1,005 completed. 99 of these trials are in Phase 3-4 (later-stage) and 579 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use Disorder, with 19 trials.
Top-decile sponsor footprint
Yale University ranks in the top decile of sponsors by registered trial count (#13 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,005 of 1,138 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,492 total, page 10 of 30
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma
NCT04955743
In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans
NCT04920539
Feasibility of Elder Mistreatment VOICES-CI Screening Tool
NCT05216081
Transgender Health: an Educational RCT
NCT05080335
A Digital Intervention for HIV Prevention in Black Adolescent Girls
NCT04108988
TAP Block Using Liposomal Bupivacaine for Post-cesarean Delivery Analgesia- Walking Towards Recovery
NCT04393207
The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients
NCT05214144
Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine
NCT04613453
MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy
NCT05054036
Virtual Physical Activity for Type 1 Diabetes
NCT05163912
Prescription Digital Therapeutic for the Treatment of Insomnia
NCT04909229
Feasibility of VOICES Elder Abuse Intervention in Primary Care Setting (VOICES-PC Feasibility)
NCT05224843
Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer Survivors
NCT04961047
Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine
NCT05076370
The Infant- Toddler Climate of Healthy Interactions for Learning and Development (I-T CHILD)
NCT05132374
Ketamine for the Treatment of Depression in Parkinson's Disease
NCT04944017
Sympathetic Activation in Obesity
NCT04946552
Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists
NCT04903717
Stimulation of the Thalamus for Arousal Restoral in Temporal Lobe Epilepsy
NCT04897776
Personalized Recommendations for Acute Kidney Injury (AKI) Care
NCT04040296
Single-Session Intervention Targeting Emotional Awareness, Clarity, and Acceptance to Reduce Depression/Anxiety
NCT05109507
Digital Interventions to Treat Hazardous Drinking
NCT04890652
Preliminary Test of Reactive Carrot Incentives in a Practice Quit Environment With Contingency Management Incentives
NCT05072301
Implementing Fit Kit Colorectal Cancer (CRC) Screening in High Risk Populations
NCT04848051
Lidocaine Patches After Cesarean Section
NCT04443569
Digoxin In Treatment of Alcohol Associated Hepatitis
NCT05014087
LGBTQ-affirmative CBT for Youth
NCT05408858
The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis
NCT05917184
Heart Watch Study: a Pragmatic Randomized Controlled Trial
NCT04468321
Feedback and Outcomes for Clinically Useful Student Services (FOCUSS)
NCT05039671
Repeat Dosing of Psilocybin in Migraine Headache
NCT04218539
Weight Regain Treatment Post-Bariatric Surgery
NCT04662801
Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes
NCT04955691
Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations
NCT04856566
Reducing Depression-related Stigma and Increasing-treatment Seeking Among Black Adolescents
NCT04890990
PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure in the Inpatient Setting
NCT04686604
Outcomes After Albumin Vs Lactated Ringer's Solution in CABG and AVR Procedures
NCT04652375
Optimal Duration of Post-Operative Activity Restriction After Midurethral Sling Procedures
NCT04817839
Assessment, Feedback, Incentive, Exchange (AFIX OB) A Customizable Quality Improvement Intervention to Increase Maternal Vaccine Uptake
NCT04678271
Neurofeedback in Individuals With Substance Use Disorders
NCT04188288
Nicotine's Potential Abuse With Menthol
NCT04535362
Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)
NCT04394715
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
NCT04649229
Infrared Wraps Effect on Oxygenation of Diabetics Arm, Feet and Lower Leg
NCT04460612
Take 5 + Audio Clip Randomized Control Trial
NCT04608877
Changes in Fitness and Strength in Postoperative Cardiac Patients Undergoing Exercise Therapy: Biological and Functional Mechanisms of Recovery
NCT04903691
Neuroimaging Mechanisms by Which Memory and Glucocorticoids Promote Risky Drinking
NCT04896489
Yale COVID-19 Recovery Study
NCT04895189
Switching to Potential Reduced Exposure Products in Adult Smokers
NCT04250727
M1 Schizophrenia PET Study
NCT05105542
What is open in the Yale University pipeline
254 recruiting of 1,492 indexed (17% open); 1,005 completed (67%).
Phase mix: 99 late (III/IV) vs 579 early (I/II) (early-phase heavy).
Top condition: Opioid Use Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Yale University: open-pipeline peers nationwide
Peers matched on 1,492 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Yale University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,492 trials (± recruiting share)
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- NYU Langone Health · 17% recruiting · 1,164 trials
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
Related
What to do with this Yale University page
1,492 registered trials is a research-attention snapshot, not an endorsement of Yale University or any single study.
- 254 of Yale University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use Disorder is the condition Yale University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Yale University pipeline card: 1,492 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.